Jeffrey del Carmen, Chief Commercial Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 60,846 shares at $22.89 ($1.4M) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Open-market sale of $1.4M CPRX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.89 | 30,423 | $696K | 50.0% |
| 2 | $22.89 | 30,423 | $696K | 50.0% |
| Total | $22.89 avg | 60,846 | $1.4M | 100% |
| Filing → |
| CPRX | SELL | 2024-06-11 | $242K | — | Filing → |
| CPRX | SELL | 2023-03-30 | $1.3M | — | Filing → |
| CPRX | SELL | 2022-11-15 | $2.5M | — | Filing → |